1. Academic Validation
  2. Discovery of a functionally selective serotonin receptor (5-HT1AR) agonist for the treatment of pain

Discovery of a functionally selective serotonin receptor (5-HT1AR) agonist for the treatment of pain

  • Sci Adv. 2025 Jun 20;11(25):eadv9267. doi: 10.1126/sciadv.adv9267.
Annika Ullrich 1 Johannes Schneider 1 João M Braz 2 Eduard Neu 1 Nico Staffen 1 Markus Stanek 1 Jana Bláhová 1 Tamsanqa Hove 3 Tamara Albert 1 Anni Allikalt 1 Stefan Löber 1 Karnika Bhardwaj 2 Sian Rodriguez-Rosado 2 Elissa Fink 4 5 Tim Rasmussen 3 Harald Hübner 1 Asuka Inoue 6 7 Brian K Shoichet 4 Allan I Basbaum 2 Bettina Böttcher 3 Dorothee Weikert 1 8 Peter Gmeiner 1 8
Affiliations

Affiliations

  • 1 Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • 2 Department of Anatomy, University of California, San Francisco, CA, USA.
  • 3 Rudolf-Virchow-Center, Julius-Maximilians-Universität, Würzburg, Germany.
  • 4 Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.
  • 5 Graduate Program in Biophysics, University of California, San Francisco, CA, USA.
  • 6 Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • 7 Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
  • 8 FAU NeW, Erlangen, Germany.
Abstract

The heterotrimeric G protein-coupled serotonin receptor 5-HT1A receptor (5-HT1AR) mediates antinociception and may serve as a valuable target for the treatment of pain. Starting from a chemical library, we evolved ST171, a bitopic 5-HT1AR agonist that revealed highly potent and functionally selective Gi/o signaling without Gs activation and marginal β-arrestin recruitment. ST171 is effective in acute and chronic pain models. Cryo-electron microscopy structures of ST171 bound to 5-HT1AR in complex with the Gi protein compared to the canonical agonist befiradol bound to complexes of 5-HT1AR with Gi or Gs revealed that the ligands occupy different exo-sites. The individual binding poses are associated with ligand-specific receptor conformations that were further studied by molecular dynamics simulations, allowing us to better understand ligand bias, a phenomenon that may be crucial to the discovery of more effective and safe G protein-coupled receptor drugs.

Figures
Products